Drug Profile
RO 700004
Alternative Names: RS 100975Latest Information Update: 25 Nov 2005
Price :
$50
*
At a glance
- Originator Roche Palo Alto LLC
- Class Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Benign prostatic hyperplasia; Erectile dysfunction
Most Recent Events
- 25 Nov 2005 No development reported - Clinical-Phase-Unknown for Erectile dysfunction in USA (PO)
- 25 Nov 2005 No development reported - Phase-II for Benign prostatic hyperplasia in USA (unspecified route)
- 29 Aug 2002 A study has been added to the adverse events and Mens Health therapeutic trials sections